Weil, Gotshal & Manges has advised Apax Partners, who held a 47.7% sta…
Weil, Gotshal & Manges has advised Apax Partners, who held a 47.7% stake in metaGen Pharmaceuticals GmbH, the German biotechnology company, on the merger of metaGen and Astex Technology Limited, the Cambridge-based biotechnology company. The merged company will operate under the name of Astex Technology Limited. Financial details of the transaction were not disclosed. This […]
Weil, Gotshal & Manges has advised Apax Partners, who held a 47.7% sta… Read More »